Tonabersat is a compound investigated as a potential antimigraine agent. It is supplied as a pharmaceutical raw material for research and manufacturing purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 175013-84-0
Levomilnacipran hydrochloride
pharmaceutical raw material
Gemifloxacin
pharmaceutical raw material
Lacosamide
pharmaceutical raw material
Tapentadol hydrochloride
pharmaceutical raw material
N-[(3S,4S)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-3-chloro-4-fluorobenzamide
XLIIRNOPGJTBJD-ROUUACIJSA-N
CC(=O)C1=CC2=C(C=C1)OC([C@H]([C@H]2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C